• CONTACT
  • NEWS & MEDIA
  • UPCOMING EVENTS
  • Canady Helios Cold Plasma
  • Canady Hybrid Plasma
    • Canady Hybrid Plasma Technology
    • Canady Plasma XL 1000 Smart Electrosurgical Generator
    • Canady Hybrid Plasma™ Scalpel
    • Canady Plasma Probes
  • Our Treatment
  • Science of Plasma
  • About Us
    • Message From CEO
    • Mission/Vision
    • Management Team
    • Company Milestones
  • Our Patients
    • PATIENT FOCUS
    • Clinical Trial
Efficacy of Hybrid Plasma Scalpel in Reducing Blood Loss and Transfusions in Direct Anterior Total Hip Arthroplasty

Efficacy of Hybrid Plasma Scalpel in Reducing Blood Loss and Transfusions in Direct Anterior Total Hip Arthroplasty

by PVA_Admin | Apr 23, 2016 | Other Publications, Publications

Efficacy of Hybrid Plasma Scalpel in Reducing Blood Loss and Transfusions in Direct Anterior Total Hip Arthroplasty George N. Guild, III, MD1, Robert P. Runner, MD, Gina M. Castilleja, RN, Melissa J. Smith, MS, ATC, Cat Phuong L. Vu, BA Allogeneic blood transfusions...

Chinese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology

by PVA_Admin | Feb 10, 2016 | 2016 Press Release, Press Release

Chinese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a biomedical device specification manufacturer and subsidiary of US Patent Innovations,...

Japanese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology

by PVA_Admin | Feb 9, 2016 | 2016 Press Release, Press Release

Japanese Patent Office Issues Decision to Grant Patent for USMI’s Canady Hybrid Plasma™ Technology TAKOMA PARK, Md.–(BUSINESS WIRE)–US Medical Innovations, LLC (USMI), a U.S.-based biomedical device specification manufacturing company and subsidiary of US...

US Medical Innovations, LLC receives ISO 13485:2003 Certification following review of the Quality Management System for USMI, PMLS, Canady Robotics and Canady Biotechnology.

by PVA_Admin | Jan 1, 2016 | 2016 Press Release, Press Release

US Medical Innovations, LLC receives ISO 13485:2003 Certification following review of the Quality Management System for USMI, PMLS, Canady Robotics and Canady...

US Medical Innovations Announces Plans for New Robotic Surgical System

by PVA_Admin | Oct 23, 2015 | 2015 Press Release, Press Release

US Medical Innovations Announces Plans for New Robotic Surgical System TAKOMA PARK, Md.–(BUSINESS WIRE)–US Patent Innovations, LLC, filed for patent protection (United States Patent and Trademark Office) on the Canady RoboTM Surgical Systems with robotic...
« Older Entries
Next Entries »

Recent Posts

  • US Medical Innovations Secures FDA Clearance for Canady Helios Cold Plasma™ Ablation System
  • USMI TO DEBUT THE CANADY ROBOTIC AI SURGICAL SYSTEM AT THE FIRST GLOBAL SURGICAL ONCOLOGY SUMMIT JERUSALEM, ISRAEL JANUARY 2024
  • Groundbreaking Results Using Canady Helios™ Cold Plasma Treatment Published in MDPI Journal “Cancers”
  • The First Cold Atmospheric Plasma Phase I Clinical Trial for the Treatment of Advanced Solid Tumors: A Novel Treatment Arm for Cancer
  • USMI Receives FDA Approval for New Robotic Surgery Device – The Canady Flex RoboWrist™

Recent Comments

No comments to show.

CANADY HELIOS COLD PLASMA ›

CANADY HYBRID PLASMA ›

OUR TREATMENT ›

SCIENCE OF PLASMA ›

ABOUT US ›

OUR PATIENTS ›

NEWS & MEDIA ›

CONTACT USMI ›

Copyright © 2025 US Medical Innovations